NCT07349303 2026-01-21
NEOPRIME
Vastra Gotaland Region
Phase 2 Recruiting
Clinical Trials
12 trialsNCT05304546 2025-07-22
MK3475-C01
Sheba Medical Center
Phase 2 Completed
NCT06670300 2024-11-01
Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT04924413 2024-07-03
L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma
Henan Cancer Hospital
Phase 2 Terminated
NCT04242329 2024-01-26
SUMMIST
Vastra Gotaland Region
Phase 2 Withdrawn
NCT02697630 2023-12-08
PEMDAC
Vastra Gotaland Region
Phase 2 Completed
NCT03166397 2023-01-26
Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients
Sheba Medical Center
Phase 2 Recruiting
NCT05315128 2022-04-07
Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers
Zagazig University
Phase 2 Completed
NCT02533700 2020-03-10
CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL
Shandong Provincial Hospital
Phase 2 Unknown
NCT03986515 2019-06-14
Apatinib Plus SHR1210 in Advanced Mucosal Melanoma
Henan Cancer Hospital
Phase 2 Unknown
NCT03383237 2017-12-27
Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma
Henan Cancer Hospital
Phase 2 Unknown
NCT00287131 2012-03-29
Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients
Sheba Medical Center
Phase 2 Unknown